What are the most common reasons a proposal is declined?
- The proposed project has no relation to nursing regulation or policy.
- The proposal is poorly written, difficult to understand or not written using a scientific framework.
- The proposal does not describe how the statistical analysis of the data will be performed.
- The proposal has methodological errors, inadequate control of subject variables, incorrect or inappropriate research design, or poor conceptualization of the problem/approach and statistical analysis.
- The proposal did not follow CRE general grant guidelines.
- The study is not generalizable beyond a small or specialized group.
- Expenditures are excessive. The budget is not in line with the proposed project.
Can more than one investigator from an institution apply for a grant in the same funding cycle?
Can an individual receive more than one grant?
Yes, but not within the same calendar year.
How long does it take for a grant to be approved?
About three to four months. Please review the CRE Grant Timeline for further details.
Are grants only given to nurses or also to non-nurses doing research in nursing?
Grants will be awarded to non-nurses as well as nurses as long as the research pertains to nursing regulation. A list of past grant recipients is available here.
Is IRB approval required before a grant proposal can be submitted?
No, but grant payments will not be provided until proof of IRB approval is received. Many proposal are submitted with IRB review pending.
My instruments are not yet developed; can I still apply?
Unless the study involves the development of a research instrument, all measurement/survey instruments must be selected and/or developed prior to proposal submission so that the project is ready to begin upon notice of funding. Validity and reliability of the instrument must be included in the proposal.
If a grant proposal is not approved, can the project team re-submit?
Yes. It is recommended to request feedback from the CRE review panel prior to re-submitting the application.